The Active Pharmaceutical Ingredient Industry, valued at USD 237.5 billion in 2023, is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.8% from 2024 to 2031, reaching an estimated USD 372.8 billion by 2031. This robust growth is driven by increasing prevalence of chronic diseases, rising demand for generic drugs, and advancements in API manufacturing technologies. Key Growth...